| Literature DB >> 25258678 |
Prashi Jain1, Jiaqin Li2, Patrick Porubsky1, Benjamin Neuenswander3, Susan M Egan2, Jeffrey Aubé4, Steven Rogers5.
Abstract
During a structure-activity relationship optimization campaign to develop an inhibitor of AraC family transcriptional activators, we discovered an unexpected transformation of a previously reported inhibitor that occurs under the assay conditions. Once placed in the assay media, the 3, 4-disubstituted dihydroquinoline core of the active analogue rapidly undergoes a decomposition reaction to a quaternary 3-substituted biquinolinium. Further examination established an SAR for this chemotype while also demonstrating its resilience to irreversible binding of biologically relevant nucleophiles.Entities:
Year: 2014 PMID: 25258678 PMCID: PMC4170738 DOI: 10.1039/C4RA08384A
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 3.361